La Cardiomiopatía de Takotsubo es una enfermedad cardíaca aguda con una presentación clínica similar al síndrome coronario agudo. Afecta principalmente a mujeres posmenopáusicas, a menudo precedido por estrés emocional o físico. Pacientes con factores predisponentes como malignidad y comorbilidades crónicas son más propensas a sufrir este síndrome. La patogénesis no está clara y se han propuesto como mecanismos: espasmo coronario, disfunción microvascular, infarto miocárdico abortado, obstrucción del tracto de salida del ventrículo izquierdo, toxicidad miocárdica por catecolaminas, y disfunción autonómica; pero hasta el momento no se ha logrado establecer con claridad la causa exacta de esta patología. Se describe el caso de una mujer posmenopáusica con un cuadro clínico inicial similar a un Síndrome Coronario Agudo, quien fue llevada a coronariografía como parte del protocolo del Síndrome Coronario, sin lesiones significativas, pero en la ventriculografía se observó el abalonamiento apical, característico de este síndrome. Se inició manejo de soporte, alcanzando la recuperación completa de la paciente, no obstante, hasta el momento no se ha descrito un manejo específico para esta patología. Se requieren más investigaciones para aclarar la fisiopatología de esta Cardiomiopatía y así protocolizar un manejo de terapia dirigida que logre un mejor pronóstico en nuestros pacientes.
Chronic thromboembolic pulmonary hypertension (CTEPH) is a distinct subtype of pulmonary hypertension arising from persistent major pulmonary artery obstruction after pulmonary embolism. Pulmonary endarterectomy (PEA) remains the standard of care, but up to 40% of patients in European and US registries are inoperable; balloon pulmonary angioplasty (BPA) has emerged as a more accessible interventional modality for suitable patients. This retrospective single‐center cohort study evaluated functional improvement, hemodynamic response, and mortality in patients with CTEPH ineligible for PEA who underwent BPA at a Colombian institution (May 2022–October 2025). Risk was stratified using COMPERA 2.0. The primary outcome was improvement of at least one New York Heart Association (NYHA) functional class; secondary outcomes were change in mean pulmonary arterial pressure (mPAP) and all‐cause mortality during follow‐up. Of 33 patients (median age 63 years; 70% female), 5 (15.1%) were high risk at baseline, 16 (48.4%) intermediate‐high, 10 (30.3%) intermediate‐low, and 2 (6%) low risk. After BPA, 19 patients (58%) improved NYHA class (95% CI, 39.2%–74.5%), and mPAP fell from 60 (IQR 50–68) to 40 mmHg (IQR 37–48) after a median of three sessions (IQR 2–4) (mean paired reduction 14.05 mmHg, 95% credible interval 9.81–18.07; Hedges’ g = 1.22, 95% CI 0.77–1.66). Two deaths (6.0%) occurred, both in high‐risk patients. BPA improved NYHA class and pulmonary hemodynamics in severe, inoperable CTEPH, with a low complication rate despite advanced baseline disease. COMPERA 2.0 stratified baseline severity but did not predict the magnitude of hemodynamic response to BPA, consistent with the mechanical nature of the disease.
BACKGROUND Acquired ventricular septal defect is an uncommon complication of myocardial infarction that can require surgical repair. Percutaneous closure techniques avoid the risks associated with major cardiac surgery, particularly in elderly patients. This report presents the case of a 73-year-old man with a post-infarction ventricular septal defect successfully treated by percutaneous closure. CASE REPORT A 73-year-old man was admitted with ST-elevation myocardial infarction. Coronary angiography revealed 2-vessel disease, and successful stenting of the left anterior descending artery was performed. Transthoracic echocardiography demonstrated an apical ventricular septal defect. Given the patient's hemodynamic stability, the heart team recommended delayed percutaneous closure. However, the patient requested voluntary discharge. He was readmitted 2 weeks later with dyspnea and chest pain. The defect was closed percutaneously due to technical feasibility, elevated surgical risk, and patient preference. Post-procedural recovery was uneventful, and he was in NYHA functional class I at outpatient follow-up. CONCLUSIONS Ischemic ventricular septal rupture is a rare but potentially fatal complication of transmural myocardial infarction, requiring prompt recognition and management by a heart team. Presentation ranges from chest pain or a new murmur to cardiogenic shock. Diagnosis relies on imaging modalities, including transthoracic or transesophageal echocardiography and cardiac magnetic resonance imaging. Management options include surgical and percutaneous closure, with ventricular septal rupture repair mortality exceeding 40%. Treatment selection depends on the patient's clinical status and the size, location, and complexity of the defect. This report highlights the role of percutaneous closure in post-infarction ventricular septal rupture and illustrates a successful outcome in an elderly patient.